Nemaura Medical Inc
F:N18A
Balance Sheet
Balance Sheet Decomposition
Nemaura Medical Inc
Nemaura Medical Inc
Balance Sheet
Nemaura Medical Inc
| Mar-2014 | Mar-2015 | Mar-2016 | Mar-2017 | Mar-2018 | Mar-2019 | Mar-2020 | Mar-2021 | Mar-2022 | Mar-2023 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||
| Cash & Cash Equivalents |
2
|
0
|
9
|
1
|
1
|
4
|
0
|
32
|
18
|
10
|
|
| Cash |
2
|
0
|
9
|
1
|
1
|
4
|
0
|
32
|
18
|
10
|
|
| Short-Term Investments |
0
|
0
|
0
|
2
|
5
|
0
|
0
|
0
|
0
|
0
|
|
| Total Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Accounts Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Inventory |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
2
|
|
| Other Current Assets |
0
|
0
|
0
|
0
|
0
|
1
|
0
|
1
|
0
|
1
|
|
| Total Current Assets |
2
|
1
|
10
|
3
|
6
|
5
|
1
|
34
|
20
|
14
|
|
| PP&E Net |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
|
| PP&E Gross |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
|
| Accumulated Depreciation |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Intangible Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
0
|
|
| Long-Term Investments |
0
|
0
|
0
|
4
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Long-Term Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Assets |
2
N/A
|
1
-56%
|
10
+969%
|
7
-24%
|
6
-15%
|
5
-24%
|
1
-74%
|
35
+2 789%
|
22
-37%
|
15
-34%
|
|
| Liabilities | |||||||||||
| Accounts Payable |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Accrued Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
6
|
19
|
17
|
|
| Other Current Liabilities |
0
|
0
|
1
|
1
|
1
|
1
|
1
|
0
|
1
|
5
|
|
| Total Current Liabilities |
0
|
0
|
1
|
1
|
1
|
1
|
1
|
6
|
21
|
22
|
|
| Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
19
|
0
|
3
|
|
| Other Liabilities |
2
|
2
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
|
| Total Liabilities |
2
N/A
|
2
+9%
|
2
+12%
|
2
0%
|
2
+5%
|
3
+19%
|
3
0%
|
27
+962%
|
22
-19%
|
26
+22%
|
|
| Equity | |||||||||||
| Common Stock |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Retained Earnings |
3
|
4
|
6
|
7
|
9
|
13
|
18
|
24
|
38
|
52
|
|
| Additional Paid In Capital |
3
|
3
|
13
|
13
|
13
|
16
|
17
|
32
|
38
|
41
|
|
| Other Equity |
0
|
0
|
0
|
1
|
0
|
0
|
0
|
0
|
0
|
1
|
|
| Total Equity |
0
N/A
|
1
N/A
|
8
N/A
|
5
-30%
|
4
-23%
|
2
-46%
|
1
N/A
|
8
N/A
|
0
-94%
|
12
N/A
|
|
| Total Liabilities & Equity |
2
N/A
|
1
-56%
|
10
+969%
|
7
-24%
|
6
-15%
|
5
-24%
|
1
-74%
|
35
+2 789%
|
22
-37%
|
15
-34%
|
|
| Shares Outstanding | |||||||||||
| Common Shares Outstanding |
20
|
20
|
21
|
21
|
7
|
21
|
21
|
23
|
24
|
29
|
|